• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

知识产权单方拒绝许可的经济分析

An economic analysis of unilateral refusals to license intellectual property.

作者信息

Gilbert R J, Shapiro C

机构信息

Department of Economics, University of California at Berkeley 94720, USA.

出版信息

Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12749-55. doi: 10.1073/pnas.93.23.12749.

DOI:10.1073/pnas.93.23.12749
PMID:8917489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC34132/
Abstract

The intellectual property laws in the United States provide the owners of intellectual property with discretion to license the right to use that property or to make or sell products that embody the intellectual property. However, the antitrust laws constrain the use of property, including intellectual property, by a firm with market power and may place limitations on the licensing of intellectual property. This paper focuses on one aspect of antitrust law, the so-called "essential facilities doctrine," which may impose a duty upon firms controlling an "essential facility" to make that facility available to their rivals. In the intellectual property context, an obligation to make property available is equivalent to a requirement for compulsory licensing. Compulsory licensing may embrace the requirement that the owner of software permit access to the underlying code so that others can develop compatible application programs. Compulsory licensing may undermine incentives for research and development by reducing the value of an innovation to the inventor. This paper shows that compulsory licensing also may reduce economic efficiency in the short run by facilitating the entry of inefficient producers and by promoting licensing arrangements that result in higher prices.

摘要

美国的知识产权法赋予知识产权所有者自行决定许可他人使用该知识产权的权利,或者制造、销售体现该知识产权的产品的权利。然而,反垄断法限制了具有市场支配力的企业对包括知识产权在内的财产的使用,并可能对知识产权许可加以限制。本文聚焦于反垄断法的一个方面,即所谓的“必要设施原则”,该原则可能会要求控制“必要设施”的企业向其竞争对手提供该设施。在知识产权背景下,提供财产的义务等同于强制许可的要求。强制许可可能包括要求软件所有者允许他人访问底层代码,以便其他人能够开发兼容的应用程序。强制许可可能会通过降低创新对发明者的价值来削弱研发激励。本文表明,强制许可在短期内还可能会因便利低效生产者进入市场以及促成导致价格上涨的许可安排而降低经济效率。

相似文献

1
An economic analysis of unilateral refusals to license intellectual property.知识产权单方拒绝许可的经济分析
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12749-55. doi: 10.1073/pnas.93.23.12749.
2
Compulsory Licensing of Pharmaceuticals in High-Income Countries: A Comparative Analysis.高收入国家药品强制许可:比较分析。
Milbank Q. 2022 Mar;100(1):284-313. doi: 10.1111/1468-0009.12557. Epub 2022 Mar 7.
3
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis.论知识产权制度在药品强制许可尝试中的重要性:一项横断面分析。
Global Health. 2019 Jun 27;15(1):42. doi: 10.1186/s12992-019-0485-7.
4
Divergence and Convergence of Royalty Determinations between Compulsory Licensing under the TRIPS Agreement and Ongoing Royalties as an Equitable Remedy.《与贸易有关的知识产权协定》下强制许可的特许权使用费确定与作为公平救济的持续特许权使用费之间的差异与趋同
Am J Law Med. 2020 Mar;46(1):55-88. doi: 10.1177/0098858820919553.
5
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?国际强制许可能否使药品分级定价与健康权相协调?
BMC Int Health Hum Rights. 2014 Dec 18;14:37. doi: 10.1186/s12914-014-0037-4.
6
Pharmaceutical patents: reconciling the human right to health with the incentive to invent.药品专利:在健康权与人发明激励之间寻求平衡。
Drug Discov Today. 2020 Jul;25(7):1135-1141. doi: 10.1016/j.drudis.2020.04.009. Epub 2020 Apr 20.
7
Can you shrinkwrap a cow? Protections available for the intellectual property of the animal breeding industry.你能给一头牛包上收缩膜吗?动物育种行业知识产权的可用保护措施。
Anim Genet. 2007 Dec;38(6):647-54. doi: 10.1111/j.1365-2052.2007.01656.x.
8
Compulsory licensing of patents in India.印度专利的强制许可
Pharm Pat Anal. 2016 Sep;5(6):401-406. doi: 10.4155/ppa-2016-0033. Epub 2016 Nov 2.
9
Sponsored research agreements, university and government licensing, and clinical trial agreements: special contractual and intellectual property rights considerations.赞助研究协议、大学与政府许可及临床试验协议:特殊合同及知识产权考量
J Biolaw Bus. 2003;6(4):5-13.
10
Intellectual property licensing of therapeutics during the COVID-19 crisis: lessons learnt for pandemic preparedness and response.COVID-19 危机期间治疗方法的知识产权许可:对大流行防范和应对的经验教训。
Global Health. 2024 Jul 2;20(1):52. doi: 10.1186/s12992-024-01057-5.

引用本文的文献

1
Compulsory Licensing as an Instrument to Tackle High Medicine Prices: A Realist Review of Industrial and Health Consequences.强制许可作为应对高药价的手段:对产业和健康后果的现实主义综述
Appl Health Econ Health Policy. 2025 Apr 19. doi: 10.1007/s40258-025-00956-x.
2
Science, technology, and economic growth.科学、技术与经济增长。
Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):12655-7. doi: 10.1073/pnas.93.23.12655.